Hi, I'm Charles Roberts, uh, chief investment strategist and head of venture at ARC. Uh, backgroundwise, I was a surgeon, then moved into being a biotech entrepreneur, founded several different biotech companies, including mainly at the intersection between AI and genomics. At ARC, uh, primarily I lead venture where we have a broad deep tech portfolio across private and some public companies.I work on both strategic side and day-to-day operational management leadership of the team and working very closely w ...

Amgen, by the way, also dropping almost 6% today after disappointing results for its once monthly weight loss shot. Maritide patients without type two diabetes losing an average of 20% of their body weight after one year. But the company reporting a high rate of side effects and discontinuations.It plans to adjust its dosing schedule in a phase three trial. For more on the obesity drug race, Jared Holles joins us here on set. He is a healthcare sector strategist at Missuo.Jared, great to have you with us. u ...

Final trade time. Mike Co. A fluid situation admittedly, but I'm inclined to fade the spike in crude.Tim, yeah, I think this is a movement in the biotech space you can buy. I don't think it's a huge breakout, but I like it. Karen, well, if you went home long, it's the same as buying it on the clothes. Went home long.Uber. Uber court. I think industrials are worth a lot.Take a look at Caterpillar here. ...

Crispr Technology & Applications - Crispr 基因编辑技术能够对患者的 DNA 进行精确编辑，从而识别新的治疗靶点并纠正某些疾病，扩大可治疗疾病的范围 [2] - Crispr 技术与 AI 结合，加速识别靶点和疗法，从而加快新疗法上市的速度 [3] - 癌症，尤其是无法以其他方式治疗的儿童疾病和罕见癌症，可能是 Crispr 技术首先产生影响的领域 [5] Regulatory Landscape - FDA 对新的治疗方法和技术平台持支持态度，并倾向于快速批准 [5] - 美国卫生与公众服务部 (HHS) 部长承诺支持细胞和基因治疗领域，这对行业来说是一个巨大的推动力 [7] - 众议院拨款委员会也表达了对细胞和基因治疗领域的支持，释放了积极信号 [7] Manufacturing & Supply Chain - 该公司主要在美国本土进行生产，对进口尤其是来自中国的依赖程度不高 [9] - 公司在马萨诸塞州进行生产，并在匹兹堡进行扩张 [9] - 匹兹堡的团队致力于支持当地学校的 STEM (科学、技术、工程和数学) 项目 [9]